Workflow
The Full Effects Of Tariffs To Start Showing Up In January CPI Report
Seeking Alpha· 2026-02-07 14:05
Core Viewpoint - The article does not provide specific insights or analysis regarding any companies or industries, focusing instead on the author's personal disclosures and lack of financial positions in mentioned companies [1][2]. Group 1 - The author has no stock, option, or similar derivative positions in any of the companies mentioned [1] - There are no plans to initiate any such positions within the next 72 hours [1] - The article expresses the author's own opinions and is not receiving compensation for it, aside from Seeking Alpha [1] Group 2 - Seeking Alpha clarifies that past performance is not a guarantee of future results [2] - No recommendations or advice are provided regarding the suitability of investments for particular investors [2] - The views expressed may not reflect those of Seeking Alpha as a whole, and the analysts may not be licensed or certified [2]
FDA and HHS Hammer Hims & Hers In Compounded Drug Crackdown
247Wallst· 2026-02-07 14:03
Core Viewpoint - Hims & Hers (NYSE:HIMS) shares are experiencing a significant decline of 16% in after-hours trading due to coordinated actions by two federal agencies targeting its compounded weight-loss drugs [1] Company Summary - Hims & Hers is facing regulatory scrutiny as two federal agencies have taken coordinated actions against its compounded weight-loss drugs, leading to a sharp drop in its stock price [1]
These 3 Stocks Could Be the Best Ways to Invest in the Humanoid Robot Trend
Yahoo Finance· 2026-02-07 14:02
The idea of humanoid robots that can walk, talk, and interact with people in everyday life has captivated imaginations for decades. And today, several companies are amping up their efforts to combine robotics with the latest advances in artificial intelligence (AI) to turn that science-fiction dream into reality. How will you know when "the robots are here"? Morgan Stanley research forecasts that 10% of U.S. households could own a humanoid by 2050, with the devices selling at an average price of $50,000. Ho ...
In 2026, your performance might not be reflected in your pay raise
Yahoo Finance· 2026-02-07 14:00
Core Insights - A shift is occurring in workplaces where performance reviews are being replaced by standardized annual pay raises, referred to as "peanut butter" increases [1] Group 1: Trends in Compensation - More employers are opting for across-the-board salary increases rather than performance-based raises, with less than half of organizations planning to continue merit-based pay increases [4] - Payscale estimates that base pay will increase by an average of 3.5% in 2026, which is lower than the 4.8% average increase seen in 2023 [2] - Pay increases vary by employer size, with larger firms (over 5,000 employees) averaging 3% increases, while smaller firms (under 100 employees) average 4%, and some industries like construction and technology seeing increases of up to 5% [3] Group 2: Reasons for Change - The trend away from performance-based pay is attributed to the historical bias and poor predictive power of performance reviews regarding actual performance outcomes [6] - Companies like Starbucks have already implemented flat pay increases, indicating a broader movement towards this compensation strategy [5]
ITGR Deadline: Rosen Law Firm Urges Integer Holdings Corporation (NYSE: ITGR) Stockholders to Contact the Firm for Information About Their Rights
Businesswire· 2026-02-07 14:00
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of Integer Holdings Corporation (NYSE: ITGR) between July 25, 2024 and October 22, 2025. Integer is a medical device contract manufacturer. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Integer Holdings Corpora. ...
Palantir: AI SaaS Winner Still Expensive - Bull Trap Plays Out
Seeking Alpha· 2026-02-07 14:00
Core Viewpoint - The article emphasizes the importance of conducting personal in-depth research and due diligence before making investment decisions, highlighting the inherent risks involved in trading [3]. Group 1 - The analyst expresses a beneficial long position in shares of NVDA, SOUN, and GOOG, indicating confidence in these stocks [2]. - The article is intended for informational purposes only and does not constitute professional investment advice [3]. - There is a clear distinction made between the opinions expressed in the article and those of Seeking Alpha as a whole, indicating that the views may not reflect the platform's official stance [4].
DTH: A Better International Dividend Strategy Following The 2025 Hype
Seeking Alpha· 2026-02-07 14:00
Core Insights - International value stocks experienced exceptional performance in 2025 due to low valuations and weak USD performance, leading to a mean-reversion in valuations [1] - Dividend income strategies were also effective during this period, contributing positively to investment returns [1] Summary by Category Performance - The combination of low valuation and weak USD performance resulted in a significant mean-reversion in valuations for international value stocks in 2025 [1] Investment Strategies - Dividend income strategies proved to be beneficial, enhancing overall investment returns during the year [1]
Fivespan brings amicable activism to Appian in a bid to lift the share price and build value
CNBC· 2026-02-07 14:00
Core Viewpoint - Fivespan Partners, a newly established investment firm, is taking a significant interest in Appian, aiming to enhance the company's operations, strategy, and governance while potentially seeking board representation to add value [1][4]. Group 1: Fivespan Partners Overview - Fivespan Partners, founded in October 2023, holds a 7.91% stake in Appian with an average cost of $29.73 per share [1]. - The firm is characterized by its collaborative and amicable approach to activism, preferring to work behind the scenes but willing to engage in proxy fights if necessary [1]. - Fivespan aims to maintain a portfolio of six to eight investments, averaging between $100 million to $300 million per investment, and plans to hold these investments for three to five years [1]. Group 2: Appian's Business Model and Market Position - Appian provides critical business process and management software solutions, primarily to legacy businesses with outdated technology, resulting in high customer retention rates of approximately 99% [3]. - The company operates in a market estimated to be worth $90 billion, with only about 10% penetration, allowing for consistent mid-teens revenue growth [3]. - Despite its strong fundamentals, Appian's shares are trading at a significant discount, approximately 50% lower than similar companies, at roughly 2 times sales and 3 times gross profit [3]. Group 3: Challenges Facing Appian - Appian's stock has declined by 89% over the past five years, attributed to market misconceptions regarding its exposure to artificial intelligence risks, which are not applicable to its backend process automation [4][5]. - The company has historically focused on top-line growth at the expense of profitability, resulting in low free cash flow margins compared to peers [7]. - Appian's capital allocation has been criticized, and with Fivespan's involvement, there is potential for improved management of cash flow to maximize shareholder value [8]. Group 4: Potential for Improvement - Fivespan's involvement could lead to better communication of Appian's value proposition to the market, addressing misconceptions and enhancing investor relations [6]. - As margins improve, driven by a focus on profitability alongside revenue growth, Appian is expected to transition into a cash-generating entity, necessitating disciplined capital allocation [7][8]. - Appian is on the verge of receiving at least $500 million from a corporate espionage lawsuit against Pega, which could significantly impact its market cap and financial health [8]. Group 5: Activism Strategy - Fivespan's approach to activism is expected to be "activist-lite," focusing on collaboration and strategic advice rather than aggressive tactics, with an emphasis on gaining board representation to influence capital allocation decisions [9]. - The addition of a minority shareholder representative on the board could provide valuable insights and resources for Appian, particularly in making crucial financial decisions [9].
A Once-In-A-Decade Chance To Win Big With REITs
Seeking Alpha· 2026-02-07 14:00
Group 1 - The investment landscape for REITs is currently challenging, as they enter the fifth year of a bear market, leading some investors to shift focus to more popular sectors [1] - High Yield Landlord is offering new members a promotional discount of $100 and a 30-day money-back guarantee to attract new investors [1] - The group has recently released its Top Picks for 2026, indicating a proactive approach to identifying investment opportunities [1] Group 2 - Jussi Askola, the President of Leonberg Capital, is recognized for his expertise in REIT investing and has established a value-oriented investment boutique that serves various institutional clients [2] - High Yield Landlord provides features such as multiple portfolios, buy/sell alerts, and direct access to analysts, enhancing the investment experience for its members [2]
Wall Street's wild week rattles investors' confidence while highlighting a growing divide within markets
MarketWatch· 2026-02-07 14:00
"It seems like there are two different markets right now,†one strategist says. ...